HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Phase of Trial: Phase IV
Latest Information Update: 09 May 2017
At a glance
- Drugs Boceprevir (Primary) ; Elbasvir/grazoprevir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary) ; Sofosbuvir/velpatasvir (Primary) ; Telaprevir (Primary) ; Antivirals; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms HCV-TARGET
- 01 May 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 01 May 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
- 23 Aug 2016 Results assessing effectiveness of ledipasvir/sofosbuvir combination in patients With hepatitis C virus infection and factors associated of sustained virologic response. published in the Gastroenterology